Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to antibody or antibody fragment or immunoglobulin;...
Patent
1998-02-10
2000-08-01
Dees, Jose' G.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to antibody or antibody fragment or immunoglobulin;...
424 169, 424 96, 424 185, 4241351, 4241781, 4241381, 5303913, A61K 5110, A61K 4900, A61K 39395, C07K 1600
Patent
active
060962895
ABSTRACT:
Methods are provided for close-range intraoperative, endoscopic and intravascular deflection and treatment of lesions, including tumors and non-malignant lesions. The methods use antibody fragments or subfragments labeled with isotopic and non-isotopic agents. Also provided are methods for detection and treatment of lesions with photodynamic agents and methods of treating lesions with a protein conjugated to an agent capable of being activated to emit Auger electron or other ionizing radiation. Compositions and kits useful in the above methods are also provided.
REFERENCES:
patent: 4331647 (1982-05-01), Goldenberg
patent: 4348376 (1982-09-01), Goldenberg
patent: 4361544 (1982-11-01), Goldenberg
patent: 4444744 (1984-04-01), Goldenberg
patent: 4460561 (1984-07-01), Goldenberg
patent: 4474893 (1984-10-01), Reading
patent: 4624846 (1986-11-01), Goldenberg
patent: 4782840 (1988-11-01), Martin, Jr. et al.
patent: 4818709 (1989-04-01), Primus et al.
patent: 4859449 (1989-08-01), Mattes
patent: 4932412 (1990-06-01), Goldenberg
patent: 4946778 (1990-08-01), Ladner et al.
patent: 5057313 (1991-10-01), Shih et al.
patent: 5256395 (1993-10-01), Barbet et al.
patent: 5274076 (1993-12-01), Barbet et al.
Aitken, D., et al., "A Gamma-Detecting Probe for Radioimmune Detection of CEA-Producing Tumors," Diseases of the Colon & Rectum, vol. 27, No. 5, pp. 279-282 (1984).
Allen, M., et al., "Combined Laser Therapy and Endobronchial Radiotherapy for Unresectable Lung Carcinoma With Bronchial Obstruction," American Journal of Surgery, vol. 150, pp. 71-77 (1985).
Better, M. et al., "Escherichia coli Secretion of an Active Chimeric Antibody Fragment," Science, vol. 240, pp. 1041-1042 (1988).
Carter, P., et al., "High Level Escherichia Coli Expression and Production of a Bivalent Humanized Antibody Fragment," Biotechnology, vol. 10, pp. 163-167 (1992).
Fleischer, D., "Endoscopic Laser Therapy for Gastrointestinal Disease," Acrh. Intern. Med., vol. 144, No. 6, pp. 1225-1230 (1984).
Hirano, T., et al., "Photodynamic Cancer Diagnosis and Treatment System Consisting of Pulse Lasers and an Endoscopic Spectro-Image Analyzer," Lasers in the Life Sciences, vol. 3, No. 2, pp. 89-116 (1989).
Hunter, J., et al., "Lasers in Endoscopic Gastrointestinal Surgery," The American Journal of Surgery, vol. 148, pp. 736-741 (1984).
Krishnan, I., et al., "Chimerization of Mu-9: A Colon-Specific Antigen-p Antibody Reactive with Gastrointestinal Carcinomas," Cancer, vol. 80, No. 12, pp. 2667-2674 (1987).
Leung, S., et al., "Bacterial Expression of Kemptide Fusion Protein Facilities .sup.32 P Labeling of a Humanized, Anti-Carcinoembryonic Antigen (hMN-14) Antibody Fragment," Cancer Research, vol. 55, No. 23, pp. 5968s-5972s (1995).
Milstein, C., et al., "Hybrid Hybridomas and the Production of Bi-Specific Monoclonal Antibodies," Immunology Today, vol. 5, No. 10, pp. 299-304 (1984).
Paganelli, G., et al., "Three-Stop Monoclonal Antibody Tumor Targeting in Carcinoembryonic Antigen-Positive Patients," Cancer Research, vol. 51, No. 21, pp. 5960-5966 (1991).
Schray, M., et al., "Management of Malignant Airway Obstruction: Clinical and Dosimetric Considerations Using An Iridium-192 Afterloading Technique in Conjuction with the Neodymium-Yag Laser, " Int. J. Radiation Oncology Biol. Phys., vol. 11, No. 2 pp. 193-3409 (1985).
Scerra, A., et al., "Assembly of a Functional Immunoglobulin F.sub.v Fragment in Escherichia coli, "Science, vol. 240, pp. 1038-1041 (1988).
Studier, F., et al., "Use of Bacteriophage T7 RNA Polymerase to Direct Selective High-Level Expression of Cloned Genes," J. Mol. Biol., vol. 189, No. 1, pp. 113-130 (1986).
Tatsuta, M., et al., "Diagnosis of Gastric Cancers With Fluorescein-Labeled Monoclonal Antibodies to Carcinoembryonic Antigen," Lasers in Surgery and Medicine, vol. 9, No. 4, (1989).
Wood, J., et al., "Tumor Ablation by Endoscopic Nd: YAG Laser," The American Journal of Gastroenterology, vol. 80, No. 9, pp. 715-718 (1985).
Profio, A., "Review of Fluorescence Diagnosis Using Porphyrins," SPIE--The International Society For Optical Engineering, vol. 907, pp. 150-156 (1988).
Paganelli, G., et al., "Monoclonal Antibody Pretargetting Techniques for Tumour Localization: The Avidin-Biotin System," Nuclear Medicine Communications, vol. 12, pp. 211-234 (1991).
Pelegrin, A., et al., "Antibody-Fluorescein Conjugates for Photoimmunodiagnosis of Human Colon Carcinoma in Nude Mice," Cancer, vol. 67, pp. 2529-2537 (1991).
van den Bergh, H., "Lighy and Porphyrins in Cancer Therapy," Chem. Britain, vol. 22, pp. 430-439 (1986).
Dougherty, T., et al., "Photoradiation Therapy for the Treatment of Malignant Tumors," Cancer Research, vol. 38, pp. 2628-2635 (1978).
Dougherty, T., et al., "Photosensitizers: Therapy and Detection of Malignant Tumors," Photochem. and Photobiology, vol. 45, No. 6, pp. 879-889 (1987).
Doiron, D., et al., "Fluorescence Bronchoscopy for Detection of Lung Cancer," Chest, vol. 76, No. 1, pp. 27-32 (1979).
Mew, D., et al., "Photoimmunotherapy: Treatment of Animal Tumors with Tumor-Specific Monoclonal Antibody-Hematoporphyrin Conjugates," Journal of Immunology, vol. 130, No. 3, pp. 1473-1477 (1983).
Mew, D., et al., "Ability of Specific Monoclonal Antibodies and Conventional Antisera Conjugated to Hematoporphyrin to Label and Kill Selected Cell Lines Subsequent to Light Activation," Cancer Research, vol. 45, pp. 4380-4386 (1985).
Oseroff, A., et al., "Antibody-Targeted Photolysis: Selective Photodestruction of Human T-Cell Leukemia Cells Using Monoclonal-Chlorin e.sub.6 Conjugates," Proc. Natl. Acad. Sci. USA, vol. 83, pp. 8744-8748 (1986).
Oseroff, A., et al., "Strategies for Selective Cancer Photochemotherapy: Antibody-Targeted and Selective Carcinoma Cell Photolysis," Photochemistry and Photobiology, vol. 46, No. 1, pp. 83-96 (1987).
Hasan, T., et al., "Laser-Induced Selective Cytotoxicity Using Monoclonal Antibody-Chromophore Conjugates," Immunity to Cancer, vol. II, pp. 471-477 (1989).
Adams, G., et al., "Highly Specific in Vivo Tumor Targeting by Monovalent and Divalent Forms of 741F8 Anti-c-erbB-2 Single-Chain F.sub.v," Cancer Research, vol. 53, pp. 4026-4034 (1993).
Haunschild, J., et al., "Pharmacokinetic Properties of Bivalent Miniantibodies and Comparison to Other Immunoglobulin Forms," Antibody, Immunoconjugates and Radiopharmaceuticals, vol. 8, No. 2, pp. 111-128 (1995).
Tai, M., et al., "Targeting c-erB-2 Expressing Tumors Using Single-Chain FV Monomers and Dimers," Cancer Research, vol. 55, pp. 5983s-5989s (1995).
Dees Jos,e G.
Hartley Michael G.
Immunomedics Inc.
LandOfFree
Intraoperative, intravascular, and endoscopic tumor and lesion d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intraoperative, intravascular, and endoscopic tumor and lesion d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intraoperative, intravascular, and endoscopic tumor and lesion d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-660906